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It's Spring, and Minireview
Thoughts Turn to . . . Allergies
synthesized either directly (e.g., leukotrienes) or after
activation of specific genes (e.g., for interleukins). These
mediators mobilize an array of cellular and molecular
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Bethesda, Maryland 20892 Virtually every facet of the basic paradigm outlined
above has been elaborated by an exponential growth
of new knowledge. However, in this minireview I will
concentrate on only two aspects that are uniquely re-I live in the Washington, D.C. area, so for me, April is a
lated to the FceRI itself, and so are inherently attractivewonderful month because it initiates a long temperate
targets on which to focus novel therapeutic efforts: theseason, with blossoms bursting out all over, and be-
interaction of IgE with the receptor and the immediatecause I myself am not allergic. But for many of my col-
downstream signaling events initiated by interaction ofleagues and neighbors (the best estimate would be
the receptor-bound IgE with allergen. Rapid advances insomewhere around 10%), spring is no blessing as it
both areas are giving us an in-depth view of the relevantinaugurates a prolonged season of susceptibility to
molecular mechanisms, and by limiting my focus I canbouts of sneezing and tearing and itching.
provide the general reader an intelligible snapshot ofFor the last quarter of a century, we've understood
the details that have been unearthed for this system, aspretty well what's going on in these sufferers and it's
well as some of the fundamental questions that remainroughly as follows. Several genetic loci (Barnes and
to be answered. The enormous complexities of the entireMarsh, 1998) predispose such individuals to synthesize
signaling circuits are more appropriately described ina particular form of antibody, immunoglobulin E (IgE),
lengthier formats, and insights about them may requirein response to harmless substances (ªallergensº) that
some specialized approaches (for example, see Bhallathe immune systems of nonallergic individuals wisely
and Iyengar, 1999).ignore. Like other classes of Ig, IgE is structurally differ-
IgE and Its Interaction with FceRIentiated. The amino-terminal regions of each of its two
Clarifying the mechanisms that control the synthesis ofheavy chains associate with the similarly oriented light
IgE is essential to understanding the allergic predisposi-chains to form two identical ªFabº regions containing
tion, but I shall simply note that it is a lively area ofthe combining sites that bind the allergen at their ends
research because it relates to fundamental and generic(Figure 1). The carboxy-terminal ªFcº regions of the
issues about immune regulation. There is evidence thatheavy chains of different ªisotypesº of Igs are distinctive,
the allergic response may be perpetuated through posi-and by interacting preferentially with particular serum
tive feedback loops. That is, increasing levels of IgEor cell-surface proteins can mediate characteristic func-
promote an increase in the numbers of FceRI (for exam-tions. In the case of IgE, it exhibits an exceptionally high
ple, Lantz et al., 1997) and hence enhance the likelihoodaffinity for a glycoprotein ªFc receptor,º dubbed FceRI.
that cells can be activated, and some of the productsThese receptors are diffusely distributed on the surface
of IgE-mediated activation can stimulate the produc-of mast cells and basophils in particular, but not exclu-
tion of IgE (reviewed by Vercelli and Geha, 1997). Thesively, and, depending on the concentrations of IgE in
flipside of this self-damaging phenomenon is that if onethe serum and interstitial fluid, will be variably occupied
can intervene in the downstream events, one may actu-by IgEs directed toward a variety of antigens. IgE-bear-
ally affect the primary mechanisms of allergic sensitivitying mast cells are like naval mines: when an allergen
in a salutary way. An ironic possibility is that in devel-contacts a modest number of the receptor-bound, aller-
oped and developing countries the enhanced ability togen-specific IgEs, the cells explosively release ªmedia-
torsº that are either preformed (e.g., histamine), or newly protect oneself from infectious disease may predispose
Figure 1. Schematic Diagram of the Ectodo-
mains of the a Chains of FceRI (in Green) and
of FcgRIIa (in Blue) and Their Presumed Inter-
action with the Fc Regions of IgE and IgG
FceRI is shown as a monomer with the ap-
proximate position of the putative binding site
for IgE (in red). FcgRIIa is shown as a dimer
based on the interaction of two D2 domains
as suggested by Powell et al. with the regions
homologous to the Ig-binding site on FceRI
forming a single site for IgG. The antigen-
binding sites on the Fab regions of the IgE
and IgG are shown (in yellow) as well as the
putative site on the Ig (shaded) that interacts
with the Fc receptor.
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one's immune system to busy itself with unconstructive glycosylation in this and 16 other FcR sequences ana-
lyzed by Garman et al. Whether such information ofresponses to allergens and self-components (Shirakawa
where the Fc module of IgE is likely to dock is nowet al., 1997).
sufficiently precise to pursue a rational, rather than trial-IgE was first identified more than 30 years ago, but
and-error, approach to designing small molecule inhibi-we still have only a cartoon version of its structure. The
tors is moot. However, the authors suggest a reasonablemodels we have are based on a presumed homology
way by which an empirical search can be channeled.with the structures of many individual Ig domains but
Highly homologous structures have been determinedof only a few intact, IgG, antibodies. It will be exciting
for the extracellular domains of two receptors that bindwhen we can actually see the bent configuration of IgE
IgG, at 1.7 AÊ for FcgRIIb (Sondermann et al., 1999), andthat studies using energy transfer techniques and scat-
at 2.0 AÊ resolution for FcgRIIa (Powell et al., 1999). Bothtering techniques have predicted (reviewed by Rigby et
these groups have noted the extensive network of hy-al., 1997).
drogen bonds that course between the D1 and D2 domainsThe first three-dimensional data on the receptors with
so that the two are knit together into a rigid structure.which the Fc regions of antibodies interact have recently
This explains the failure of the more rigorous spectro-been published (Garman et al., 1998; Powell et al., 1999;
scopic analyses to detect conformational changes inSondermann et al., 1999), and no crystal structure of
the receptors upon binding the immunoglobulin.an Fc receptor/Ig complex is yet available. However, a
In the crystals they analyzed, Powell et al. found thevariety of genetic, protein chemical, and immunochemi-
ectodomains of FcgRIIa to be in the form of dimerscal techniques have implicated specific regions on IgG
(Figure 1), whereas no crystallographic evidence for di-and IgE where the interaction with their cognate recep-
mers was reported by Garman et al. or Sondermann ettors is likely to take place (reviewed by Rigby et al.,
al. The dimerization interface observed in FcgRIIa is1997). One reason for wishing to define this interaction
similar to that seen in Ig-variable domains, and Powellmore definitively is the potential for such structural infor-
et al. demonstrate that the shape and electrostatic com-mation to permit one to design specific low molecular
plementarity of the contacts are more like those seenweight inhibitors. The search for simpler inhibitors is
in functional interactions than in fortuitous crystal con-likely to be stimulated if the therapeutic results using
tacts. The dimerization would enlarge the presumptivemonoclonal antibodies to IgE as inhibitors of IgE binding
Ig-binding site from a minimal 230 AÊ 2 to over 600 AÊ 2,continue to be promising (reviewed by Heusser and Jar-
the latter value being similar to the size of antibodydieu, 1997). A second reason for defining the interaction
combining sites. The investigators make the interestingmore precisely is that such data might tell us whether
proposal that this dimerization may be necessary forthere are important changes in the conformation of the
the functioning of FcgRIIa but not for FcgRIII, FcgRI, orreceptor that might influence its capacity to signal. I'll
FceRI based on the incorporation in the latter three, butconsider that subject shortly.
not the former receptor, of a dimer of signal-transducingThe tetrameric subunit structure of the so-called
g chains. The other possibility they raise, that FcgRIIaªhigh-affinityº receptor for IgE, consisting of a single
might form heterodimers with FcgRIIb is also interesting,IgE-binding a chain, a single b chain, and a dimer of g
because the latter have specialized cytoplasmic motifschains, was first described in 1983 and the initial cloning
whose phosphorylation leads to their association withof the individual components was completed in 1989.
phosphatases that can inhibit the action of receptorsAnalysis of the linear sequence, as well as a variety of
with which they are coaggregated (reviewed by DaeÈ ron,other studies, forms the basis of the schematic structure
1997).with which we have had to be satisfied until now, and
Sondermann et al. also propose a stoichiometry ofsomething more substantial has been eagerly awaited.
2:1 for the receptor:IgG complex, but in this instance itA notable advance in that direction was published last
is based on the use of a computerized docking algorithm
December. Garman et al. (1998) succeeded in resolving
and on (as-yet-unpublished) gel filtration data. They pro-
to 2.4 AÊ the extracellular portion of the IgE-binding a
pose that the receptor interacts elsewhere on the IgG
chain. The sequence data had already predicted that than is proposed by Powell et al. and by considerable
like most other Fc receptors, the polypeptide backbone other data. The end result proposed by the two groups
of this part should be woven into two discrete ªimmuno- is equivalent, but for those interested in interfering with
globulin folds,º D1 and D2, but of course many interest- the interactions, the details of how the Ig and receptors
ing details were unpredictable. The structure reported associate will be important to establish. Only direct anal-
by Garman et al. shows the D1 and D2 domains folded yses, such as each of the groups is pursuing, will answer
at an acute angle to each other where they interact over this question unambiguously.
a broad interface (Figure 1). This arrangement orients Initiating Cellular Responses
the amino- and carboxy-terminal ends centripetally with The weight of evidence indicates that in many systems,
respect to the cell so that the cleft between the domains clustering of the receptors is the fundamental event that
cannot contain the site that binds IgE. Prior mutational initiates a cellular response (reviewed by Klemm et al.,
analyses implicated clusters of four amino acid side 1998). With respect to FceRI, this occurs when the recep-
chains in each of three interstrand loops of D2: BC, C9E, tor-bound IgE interacts with a multivalent ligand, and at
and FG (reviewed by Rigby et al., 1997); and these loops least two molecular mechanisms have been proposed to
are now seen to protrude from the joint between D1 and explain how aggregation initiates signaling (see below).
D2 and are expected to point outwardly from the cell Nevertheless, the possibility that the particulars of how
surface. Interestingly, this landing field is surrounded by, IgE binds to the receptor, and of how the receptor is
aggregated, could importantly influence the signalingbut itself maintained clear of, potential sites for N-linked
Minireview
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events continues to fascinate, if not enthrall, some inves- of phosphatase inhibitors, this receptor-associated ki-
nase, though active on a soluble peptide, is unable totigators. Garman et al. consider this question and sug-
gest that the centripetally facing cleft between D1 and phosphorylate monomeric receptors, whereas in an ag-
gregate the phosphorylation of receptors is rapid. There-D2 (Figure 1) might entrap the short ectodomains of the
two g subunits, thereby either modulating the binding fore, the data suggest that it is the approximation of the
receptors coupled with the ability of receptor-associ-of IgE, or modulating the signaling function mediated
by the cytoplasmic domains of the g chains. ated Lyn to act in trans but not in cis that induces the
phosphorylation as long as there is one Lyn moleculeAs already noted, the most detailed spectroscopic
studies have failed to reveal conformational changes per aggregate. The experiments show that additional
molecules of Lyn are then recruited to phosphorylatedthat have been proposed to occur upon binding of IgE,
either in the molecule itself, or in the receptor, or both, receptors but that aggregation by itself (that is, when
the catalytic action of the kinase is deliberately inhibited)but there exist other observations that suggest that the
simple binding of monomeric IgE to FceRI may influence fails to conscript additional kinase.
The ªcoalescenceº model propounded by Baird andfunctionally important parts of the receptor. For exam-
ple, the binding affinity of the a chain of FceRI for IgE Holowka and their colleagues puts the emphasis on
lipid:protein or even lipid:lipid rather than protein:protein(and of FcgRI for IgG) are diminished when transfected
in the absence of the normally present g chains (Miller interactions, engendered by aggregation of FceRI, to
explain the initial coupling of Lyn and the receptor (re-et al., 1998; Suzuki et al., 1998). Whether this results from
the lack of the associated chain in the final receptor, or viewed by Sheets et al., 1999). They propose that the
transmembrane domains of the a chain or of the gfrom abnormal folding or posttranslational modifications
during biosynthesis, is not known. Also not yet fully chains, or both, weakly associate with saturated glyc-
erophospholipids, sphingolipids and cholesterol, lipidsexplained is the phenomenon that binding of monomeric
IgE to FceRI can substantially boost the number of re- that tend to form a ªliquid orderedº phase. Similar micro-
domains or ªraftsº are preferentially associated with pro-ceptors expressed by basophils and mast cells (see
above). Finally, minor substitutions of amino acid resi- teins, such as Thy-1, moored to the exoplasmic leaflet of
the membrane by a glycosylphosphatidylinositol anchordues in IgE's putative binding site for the Fc receptor
have been claimed to lead to a discrepancy between and with proteins such as Lyn that are yoked to the
cytoplasmic leaflet of the membrane by myristoyl andits binding affinity and its effectiveness in mediating
cellular responses when aggregated (Sayers et al., palmitoyl tethers. Baird and Holowka and colleagues
suggest that aggregation of the receptors causes their1998). However, the binding of IgE and the cellular re-
sponse to aggregation were measured at different associated lipids to coalesce with the lipid rafts con-
taining Lyn thereby facilitating and stabilizing the inter-temperatures in that study, thereby leaving uncertain
whether the discrepancy is real. Fortunately, the field is action of Lyn and receptor by forming larger, typically
detergent-resistant, low-density microdomains. Analo-now well positioned to investigate these phenomena
experimentally, and the usefulness of novel notions will gous associations are being uncovered for related re-
ceptors.depend on whether they can lead to testable molecular
models. There are several questions raised by the pure coales-
cence model in which lipid:lipid interactions are not onlyDirect studies on FceRI and the closely related Fc
receptors, studies on more distant cousins such as the necessary but sufficient or paramount. First, why, if it
is just a matter of the degree of coalescence, shouldclonotypic antigen receptors on T and B lymphocytes,
and studies of unrelated receptors that also phosphory- there be such a dramaticÐessentially all or noneÐ
difference between the ability of monomers and dimerslate tyrosines as an early step in signaling have all con-
tributed to our current understanding of how FceRI initi- to trigger the initial events? Second, if aggregates of
FceRI coalesce with lipid domains containing Lyn, whyates cellular responses. There is general agreement that
the action starts by a phosphorylation of tyrosines on don't they similarly coalesce with lipid domains sur-
rounding unaggregated receptors? That they don't isthe b and g chains of FceRI by the src-family kinase
Lyn, although several aspects are still unexplored or indicated by the well-documented total absence of ªby-
standerº effects. That is, only the specifically aggre-disputed. For example, in related systems it appears
that the activity of the src-family kinase is itself closely gated FceRI are phosphorylated and never other FceRI
on the same cell. This result is predicted by the trans-controlled by kinases and phosphatases that modify a
regulatory tyrosine on the enzyme. With respect to phosphorylation but not by the coalescence model with-
out some additional assumptions.FceRI, there is no persuasive evidence for a receptor-
mediated change in the specific activity of the Lyn kinase This is not a trivial point because it is the constitutive
interaction between Lyn and the Fc receptor that is asufficient to account for the marked increase in the rate
of phosphorylation of its substrate when signaling is particularly appealing therapeutic target either as an
alternative, or as a supplement to interfering with theinitiated.
There are alternative, possibly complementary, mod- interaction of IgE with the receptor. The reason for this is
that like the latter interaction, the contact area betweenels that have been proposed to explain how aggregation
of the FceRI stimulates signaling pathways. A ªtrans- kinase and the unphosphorylated receptor is one of the
limited number of loci that are relatively specific to thisphosphorylationº paradigm our group uses to orient our
studies is founded on several experimental results (re- particular system. Interfering with these interactions, as
opposed to interrupting steps common to multiple sig-viewed by Metzger et al., 1999). A small fraction of mono-
meric receptors are constitutively associated with Lyn naling pathways, would be less likely to induce un-
wanted side effects.kinase. In the resting cell, and in vitro in the presence
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Shirakawa, T., Enomoto, T., Shimazu, S., and Hopkin, J.M. (1997).As reviewed in Cell a year ago (Alberts, 1998), there
Science 275, 77±79.is increasing evidence that many of the most important
Sondermann, P., Huber, R., and Jacob, U. (1999). EMBO J. 18,cellular processes are carried out by supramolecular
1095±1103.assemblies (ªprotein machinesº), and the events trig-
Suzuki, K., Hirose, T., Matsuda, H., Hasegawa, S., Okumura, K., andgered by FceRI and related immunoreceptors accord
Ra, C. (1998). Mol. Immunol. 35, 259±270.with this pattern. Both direct observations, such as from
Vercelli, D., and Geha, R.S. (1997) In Allergy, A. P. Kaplan, ed. (Phila-chemical cross-linking studies, as well as some indirect
delphia: W. B. Saunders Co.), chapt. 7, pp. 82±91.
functional data suggest that a variety of ªdownstreamº
components of the signaling cascade are physically as-
sociated with the receptor. The functional evidence
comes from the observation that the distal perturbations
triggered by FceRI and the T cell receptors are subject
to ªkinetic proofreadingº (Hopfield, 1974; McKeithan,
1995). That is, the ability to activate downstream compo-
nents appears to be sensitive to the lifetime of the initial
stimulating complex even under conditions where the
strength of the initiating signal (phosphorylation of re-
ceptor tyrosines) appears to be more than adequate.
The most straightforward interpretation of this finding
is that the late events being monitored are dependent
upon signals from molecular complexes whose activity
is totally dependent on the maintenance of the phos-
phorylated state of the individual receptor with which
they are directly or indirectly associated. This phosphor-
ylation is only sustained as long as that receptor remains
approximated to the kinase(s) in an aggregate.
Achieving a picture of supramolecular signaling com-
plexes comparable in high resolution to what has now
been begun for the interaction between IgE and IgG and
their receptors is an exciting methodological challenge.
Elucidating these interactions could promote the devel-
opment of new inhibitors of allergic reactions so that
everyone could enjoy spring fully.
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